Underserved Focus Target buyers and partners seeking affordable diagnostics and therapeutics for neglected diseases and low-resource settings, aligning with PAI Life Sciences’ mission to serve the underserved and develop products for global health accessibility.

COVID Diagnostic Opportunity capitalize on collaboration potential around rapid, affordable COVID-19 diagnostics, leveraging past joint development with Hemex Health to pursue scalable six-minute tests in emerging markets and under-resourced regions.

Translational Pipeline Position as a bridge from lab discovery to bedside by highlighting capabilities in developmental and translational research for infectious diseases and cancer therapeutics, offering end-to-end collaboration for early-stage product advancement.

Strategic Partnerships Explore co-development, manufacturing, and distribution partnerships with bigger CROs and contract manufacturers to scale operations, given the small team size and potential for consortium-driven programs.

Budget-Friendly Partnerships Target cost-conscious stakeholders by emphasizing affordable solutions and potential grant-backed programs, aligning with a revenue range of one to ten million while presenting scalable opportunities for larger collaborators.